Stocks / NYSE / Haleon plc

Haleon plc

Our Opinion

Haleon plc is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Supporting Evidence:

The company mentioned on its website that they use animals for drug testing.

“As a purpose-led business, focussed on delivering better everyday health with humanity, we understand the strength of feeling and sensitivity around the use of animals in research. We only use animals in the development of new products where alternative forms of testing do not exist, and where there is a specific scientific, legal, or regulatory requirement to do so, in order to ensure our products are safe and deliver the intended health benefits.” Read the following article

Company Description

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

Company Website: